<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01079416</url>
  </required_header>
  <id_info>
    <org_study_id>01-11-047-12</org_study_id>
    <secondary_id>K24DK002650</secondary_id>
    <nct_id>NCT01079416</nct_id>
  </id_info>
  <brief_title>Study of Capsule Endoscopy to Determine the Accuracy for Detection of Esophageal Varices</brief_title>
  <official_title>Is Capsule Endoscopy Accurate and Cost-effective Enough to Screen Cirrhotic Patients for Varices &amp; Other Lesions?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Los Angeles</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Esophageal capsule endoscopy is sedation-less alternative to upper endoscopy for evaluating
      esophageal lesions and potentially other upper gastrointestinal lesions. The purpose of this
      study was to determine whether esophageal capsule endoscopy is convenient and accurate as
      upper endoscopy for detection of esophageal varices and related lesions.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2006</start_date>
  <completion_date type="Actual">February 2008</completion_date>
  <primary_completion_date type="Actual">February 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The accuracy of capsule endoscopy for detecting esophageal varices</measure>
    <time_frame>June 2006-February 2008</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to perform and interpret capsule endoscopy study</measure>
    <time_frame>June 2006-February 2008</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">65</enrollment>
  <condition>Esophageal Varices</condition>
  <arm_group>
    <arm_group_label>Capsule endoscopy</arm_group_label>
    <description>Study device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Esophagogastroduodenoscopy</arm_group_label>
    <description>Gold standard</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Capsule endoscopy, Esophagogastroduodenoscopy</intervention_name>
    <arm_group_label>Capsule endoscopy</arm_group_label>
    <arm_group_label>Esophagogastroduodenoscopy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Cirrhotic patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age at least 18 years and less than 86 years at the time of consent.

          -  Clinically evident or biopsy proven cirrhosis.

          -  No previous documented UGI bleeding due to peptic ulcers, varices, portal hypertensive
             gastropathy, angiomas, or watermelon stomach.

          -  No previous endoscopic, radiological or surgical treatment for variceal bleeding or
             ascites.

          -  Probable life expectancy of at least 24 months without liver transplantation, as
             judged by the hepatologist and endoscopist-investigators, and have a Model for
             End-Stage Liver Disease (MELD) score â‰¤ 29.

          -  Signed a written informed consent.

        Exclusion Criteria:

          -  Prior variceal bleeding- esophageal, gastric, or other site.

          -  Prior endoscopic (e.g. sclerotherapy, ligation, or combination therapy), radiological
             (e.g. transjugular intrahepatic portosystemic shunt-TIPS) or surgical (e.g. portocaval
             or splenorenal shunt) treatment of esophagogastric varices or ascites.

          -  Patient who was uncooperative or unable to give written consent.

          -  Severe co-morbid illness, e.g. end stage chronic renal disease (e.g. dialysis
             dependence, creatinine greater than 2 times normal) or respiratory failure (e.g.
             ventilator dependent, oxygen dependent, unstable asthma or chronic obstructive
             pulmonary disease- e.g. 2 or more hospitalizations for exacerbation in 1 year, asthma
             or obstructive pulmonary disease which required daily bronchodilators and/or
             oral/inhaled steroids), tense ascites requiring repeated therapeutic paracenteses,
             severe hepatic encephalopathy, peritonitis, or sepsis.

          -  Active cancer with less than a 24 month expected survival and/or cancer on active
             treatment with chemotherapy and/or radiation therapy.

          -  Esophageal motility disorder, esophageal stricture or esophageal diverticulum, causing
             dysphagia or requiring dilatation.

          -  GI obstruction or partial obstruction (by history or imaging), symptomatic GI
             stricture or pseudo-obstruction which may prevent passage of the capsule.

          -  Patients with potentially reversible portal hypertension such as alcoholic hepatitis,
             acute viral hepatitis, untreated autoimmune hepatitis, or chronic hepatitis B or C on
             viral therapy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>UCLA</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>11301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Jensen DM. Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. Gastroenterology. 2002 May;122(6):1620-30. Review.</citation>
    <PMID>12016427</PMID>
  </reference>
  <reference>
    <citation>Jutabha R, Jensen DM, Martin P, Savides T, Han SH, Gornbein J. Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high-risk esophageal varices. Gastroenterology. 2005 Apr;128(4):870-81.</citation>
    <PMID>15825071</PMID>
  </reference>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2010</study_first_submitted>
  <study_first_submitted_qc>March 2, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2010</study_first_posted>
  <last_update_submitted>January 31, 2013</last_update_submitted>
  <last_update_submitted_qc>January 31, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 1, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Los Angeles</investigator_affiliation>
    <investigator_full_name>Disaya Chavalitdhamrong</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Esophageal Capsule Endoscopy, Screening</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Varicose Veins</mesh_term>
    <mesh_term>Esophageal and Gastric Varices</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

